Changes in pH and blood flow induced by glucose, and their effects on hyperthermia with or without BCNU in RIF-1
1Department of Radiation Oncology, Stanford University School of Medicine, CA 94305.
Abstract:
The changes in pH and blood flow of tumours caused by hyperglycaemia, and their effects on hyperthermia with BCNU, were investigated using RIF-1 tumours which grew intradermally in the thigh of C3H mice. The pH of the tumour was measured by inserting a microelectrode into the tumour. The blood flow in the tumour was estimated by flow cytometry from the uptake of the bisbenzamide fluorochrome Hoechst 33342 into the tumour. Administration of glucose resulted in a transient drop of both pH and blood flow of the tumour. The change in blood flow appeared earlier than that in pH. The response of the tumour to heat was enhanced by the administration of glucose in a time- and dose-dependent fashion, and closely correlated to the change in tumour pH. Glucose administration reduced the cytotoxicity of BCNU. This can be explained by the inhibitory effect of glucose on tumour blood flow. The effect of BCNU was enhanced by hyperthermia. This combined effect of heat and BCNU was further enhanced by the addition of glucose, but this effect was not dramatic. Because glucose inhibits blood flow in the RIF system at least, glucose is more effective for thermotherapy than for thermochemotherapy.
More Related Videos
10:23A Computational Modeling Approach to Investigate the Influence of Hyperthermia on the Tumor Microenvironment
Published on: December 1, 2023
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
